Bio-Rad's Q1 Revenues Rise 7 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories reported after the close of the market Tuesday that its first-quarter revenues increased 7 percent year over year, led by its Clinical Diagnostics segment.

The Hercules, Calif.-based firm had total revenues of $485.1 million for the three-month period ended March 31, compared to $454.2 million for Q1 2010. On a currency-neutral basis, its revenues increased 5 percent. Bio-Rad beat analysts' consensus estimate for revenues of $482.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.